Table 2.
Pharmacokinetics (Nilotinib 2008)
| Route and formulation | Oral: 200 mg caps |
|---|---|
| Absorption | Tmax 3 hours |
| Plasma half-life | 15–17 hours |
| Metabolism | By CYP 3A4, through oxidation and hydroxilation |
| Excretion | Mostly in feces |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.